William Schaffner

39.9k total citations · 7 hit papers
453 papers, 21.1k citations indexed

About

William Schaffner is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, William Schaffner has authored 453 papers receiving a total of 21.1k indexed citations (citations by other indexed papers that have themselves been cited), including 262 papers in Epidemiology, 164 papers in Infectious Diseases and 68 papers in Public Health, Environmental and Occupational Health. Recurrent topics in William Schaffner's work include Pneumonia and Respiratory Infections (128 papers), Respiratory viral infections research (105 papers) and Influenza Virus Research Studies (84 papers). William Schaffner is often cited by papers focused on Pneumonia and Respiratory Infections (128 papers), Respiratory viral infections research (105 papers) and Influenza Virus Research Studies (84 papers). William Schaffner collaborates with scholars based in United States, Kenya and Vietnam. William Schaffner's co-authors include Allen S. Craig, Monica M. Farley, Lee H. Harrison, Ann Thomas, Arthur Reingold, Wayne A. Ray, Ruth Lynfield, Marie R. Griffin, Nancy M. Bennett and Cynthia G. Whitney and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

William Schaffner

435 papers receiving 19.7k citations

Hit Papers

Sustained Reductions in Invasive Pneu... 1987 2026 2000 2013 2009 1987 2006 2011 2007 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
    2009 1.0k citations Monica M. Farley, James L. Hadler et al. profile →
  2. Psychotropic Drug Use and the Risk of Hip Fracture
    1987 808 citations William Schaffner et al. profile →
  3. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
    2006 653 citations Ruth Lynfield, William Schaffner et al. profile →
  4. Bacterial Meningitis in the United States, 1998–2007
    2011 632 citations Ruth Lynfield, James L. Hadler et al. profile →
  5. Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
    2007 609 citations Lee H. Harrison, James L. Hadler et al. profile →
  6. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
    2006 503 citations Monica M. Farley, William Schaffner et al. profile →
  7. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015
    2019 254 citations Susan Petit, Lee H. Harrison et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Schaffner United States 73 11.7k 5.1k 3.9k 3.4k 1.4k 453 21.1k
Arthur Reingold United States 81 17.8k 1.5× 8.2k 1.6× 6.2k 1.6× 5.6k 1.6× 1.2k 0.8× 300 27.7k
Ruth Lynfield United States 59 10.8k 0.9× 5.8k 1.1× 3.3k 0.9× 5.0k 1.5× 1.7k 1.2× 274 19.2k
Keith P. Klugman United States 79 18.5k 1.6× 4.2k 0.8× 6.6k 1.7× 2.7k 0.8× 1.6k 1.1× 395 25.0k
Robert F. Breiman United States 87 11.6k 1.0× 10.3k 2.0× 2.4k 0.6× 6.2k 1.8× 1.4k 1.0× 391 25.8k
Cynthia G. Whitney United States 68 21.2k 1.8× 3.7k 0.7× 6.8k 1.8× 2.5k 0.7× 783 0.6× 256 26.0k
Anne Schuchat United States 68 13.5k 1.2× 3.4k 0.7× 5.1k 1.3× 9.4k 2.7× 829 0.6× 186 23.3k
Katherine L. O’Brien United States 66 13.5k 1.2× 2.9k 0.6× 4.6k 1.2× 2.8k 0.8× 796 0.6× 257 19.2k
Benjamin Schwartz United States 68 5.6k 0.5× 4.9k 1.0× 1.5k 0.4× 4.4k 1.3× 821 0.6× 187 13.5k
Lee H. Harrison United States 85 19.7k 1.7× 10.0k 2.0× 8.7k 2.2× 6.0k 1.8× 2.0k 1.5× 389 29.9k
Monica M. Farley United States 79 18.8k 1.6× 9.4k 1.9× 6.8k 1.8× 7.2k 2.1× 1.9k 1.3× 235 28.0k

Countries citing papers authored by William Schaffner

Since Specialization
Citations

This map shows the geographic impact of William Schaffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Schaffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Schaffner more than expected).

Fields of papers citing papers by William Schaffner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Schaffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Schaffner. The network helps show where William Schaffner may publish in the future.

Co-authorship network of co-authors of William Schaffner

This figure shows the co-authorship network connecting the top 25 collaborators of William Schaffner. A scholar is included among the top collaborators of William Schaffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Schaffner. William Schaffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
See, Isaac, Kelly A. Jackson, Kelly M Hatfield, et al.. (2025). Characteristics of nursing homes with high rates of invasive methicillin‐resistant Staphylococcus aureus infections. Journal of the American Geriatrics Society. 73(3). 849–858. 1 indexed citations
2.
Talbot, H. Keipp, Yuwei Zhu, Danielle Ndi, et al.. (2025). Respiratory syncytial virus: an under-recognized healthcare-associated infection. Infection Control and Hospital Epidemiology. 46(6). 611–615. 1 indexed citations
3.
Thomas, Christine, Reneé M. Johnson, Caleb Wiedeman, et al.. (2024). Lessons Learned From Implementation of Mpox Surveillance During an Outbreak Response in Tennessee, 2022. Public Health Reports. 139(5). 566–572. 3 indexed citations
4.
Smith, Kenneth J., Angela R. Wateska, Mary Patricia Nowalk, et al.. (2024). Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older Adults. American Journal of Preventive Medicine. 68(3). 518–526. 3 indexed citations
5.
Zhu, Yuwei, Dayna Wyatt, Tiffanie Markus, et al.. (2024). Estimating the Undetected Burden of Respiratory Syncytial Virus Hospitalizations in Adults Through Capture–Recapture Methods. Influenza and Other Respiratory Viruses. 18(5). e13299–e13299. 1 indexed citations
6.
Thomas, Christine, S.A. Roberts, Mary‐Margaret A. Fill, et al.. (2024). Inequities in Hepatitis Virus Testing for Perinatally Exposed Infants in Tennessee: 2018 to 2023. PEDIATRICS. 154(6).
7.
Wateska, Angela R., Mary Patricia Nowalk, Chyongchiou J. Lin, et al.. (2023). Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults. Vaccine. 41(30). 4431–4437. 9 indexed citations
8.
Nadle, Joelle, Susan M. Ray, Ruth Lynfield, et al.. (2022). Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019. SHILAP Revista de lepidopterología. 2(S1). s63–s64.
9.
Wateska, Angela R., Mary Patricia Nowalk, Hawre Jalal, et al.. (2021). Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Α value of information analysis. Vaccine. 39(27). 3608–3613.
10.
Vandekar, Simon, Andrew J. Spieker, Herdi Rahman, et al.. (2020). Epidemiological Trends of Racial Differences in Early- and Late-onset Group B Streptococcus Disease in Tennessee. Clinical Infectious Diseases. 73(11). e3634–e3640. 6 indexed citations
11.
Kline, Kelly E., James L. Hadler, Kimberly Yousey‐Hindes, et al.. (2017). Impact of pregnancy on observed sex disparities among adults hospitalized with laboratory‐confirmed influenza, FluSurv‐NET, 2010‐2012. Influenza and Other Respiratory Viruses. 11(5). 404–411. 1 indexed citations
12.
MacNeil, Jessica R., Nancy M. Bennett, Monica M. Farley, et al.. (2015). Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012. PEDIATRICS. 135(2). e305–e311. 32 indexed citations
13.
Carpenter, L. Rand, et al.. (2007). Mass Distribution of Free, Intranasally Administered Influenza Vaccine in a Public School System. PEDIATRICS. 120(1). e172–e178. 79 indexed citations
14.
Jones, Timothy F. & William Schaffner. (2001). Miniature Chest Radiograph Screening for Tuberculosis in Jails. American Journal of Respiratory and Critical Care Medicine. 164(1). 77–81. 36 indexed citations
15.
Craig, Allen S., Paul C. Erwin, William Schaffner, et al.. (1999). Carriage of Multidrug-Resistant Streptococcus pneumoniae and Impact of Chemoprophylaxis During an Outbreak of Meningitis at a Day Care Center. Clinical Infectious Diseases. 29(5). 1257–1264. 39 indexed citations
16.
Haas, David W., et al.. (1998). Nosocomial Transmission of a Drug-Sensitive W-Variant Mycobacterium tuberculosis Strain Among Patients With Acquired Immunodeficiency Syndrome in Tennessee. Infection Control and Hospital Epidemiology. 19(9). 635–639. 3 indexed citations
17.
Schaffner, William. (1991). Surgeons with HIV infection: the risk to patients. Journal of Hospital Infection. 18. 191–196. 4 indexed citations
18.
Davis, Barry J., Steven L. Solomon, Richard P. Wenzel, et al.. (1985). ICE volume 6 issue 10 Cover and Front matter. Infection Control. 6(10). f1–f6. 1 indexed citations
19.
Schaffner, William, M. Ann Melly, J. H. Hash, & Matthias Koenig. (1967). Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies [SCHAFFNER, MELLY, HASH & KOENIG].. The Yale Journal of Biology and Medicine. 39(4). 4 indexed citations
20.
Drutz, David J., et al.. (1966). Bacterial Interference in the Therapy of Recurrent Staphylococcal Infections. RePub (Erasmus University Rotterdam). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur Reingold Breakdown of academic impact, for papers by Ruth Lynfield Breakdown of academic impact, for papers by Keith P. Klugman Breakdown of academic impact, for papers by Robert F. Breiman Breakdown of academic impact, for papers by Cynthia G. Whitney Breakdown of academic impact, for papers by Anne Schuchat Breakdown of academic impact, for papers by Katherine L. O’Brien Breakdown of academic impact, for papers by Benjamin Schwartz Breakdown of academic impact, for papers by Lee H. Harrison Breakdown of academic impact, for papers by Monica M. Farley
Rankless by CCL
2026